| 注册
首页|期刊导航|中国中西医结合杂志|荣筋拈痛方抑制PARP1延缓软骨细胞衰老治疗膝骨关节炎

荣筋拈痛方抑制PARP1延缓软骨细胞衰老治疗膝骨关节炎

李璐 郑若曦 戴雨婷 王如意 陈楠 陈俊 吴广文

中国中西医结合杂志2026,Vol.46Issue(1):67-74,8.
中国中西医结合杂志2026,Vol.46Issue(1):67-74,8.DOI:10.7661/j.cjim.20251122.226

荣筋拈痛方抑制PARP1延缓软骨细胞衰老治疗膝骨关节炎

Rongjin Niantong Formula Alleviates Knee Osteoarthritis by Attenuating Chondrocyte Senescence via Inhibiting PARP1

李璐 1郑若曦 1戴雨婷 2王如意 1陈楠 2陈俊 1吴广文1

作者信息

  • 1. 福建中医药大学中医骨伤及运动康复教育部重点实验室(福州 350122)
  • 2. 福建中医药大学骨伤学院(福州 350122)
  • 折叠

摘要

Abstract

Objective To investigate the mechanism of Rongjin Niantong Formula(RJNTF)in treating knee osteoarthritis(KOA)via in delaying chondrocyte senescence through the modulation of Poly(ADP-ribose)polymerase 1(PARP1).Methods This study was divided into two experiments.In experiment one,chondrocytes were divided into the si-NC group(negative control virus),the si-PARP1 group(PARP1 knockdown),the D-galactose(D-gal)+si-NC group(negative control virus+D-gal)and the D-gal+si-PARP1 group(PARP1 knockdown+D-gal).In experiment two,chondrocytes were divided into the normal group(10%blank serum),the model group(10%blank serum+10 g/L D-gal),the treatment group(10%RJNTF drug-containing serum+10 g/L D-gal)and the inhibitor group(10%blank serum+10 g/L D-gal+10 μmol/L PJ34).Senescence was assessed by senescence-associated β-galactosidase(SA-β-gal staining),and cell proliferation was evaluated by the EdU assay.NAD+levels and the NAD+/nicotinamide adenine dinucleotide(NADH)ratio were measured.Interleukin-6(IL-6),high mobility group box 1(HMGB1),tumor necrosis factor-alpha(TNF-α)were quantified by ELISA.The mRNA and protein expression of Poly ADP-ribose 1(PARP1),multiple tumor suppressor 1(p16)and matrix metallopeptidase 13(MMP-13)were detected by RT-qPCR and Western Blot,respectively.Results Results of experiment 1:Compared with the si-NC group,the positive rate of SA-β-gal,the expressions of IL-6,HMGB1,TNF-α,and the mRNA and protein expressions of PARP1,p16,and MMP-13 in the D-gal+si-NC group increased(P<0.01).The content of NAD+,the ratio of NAD+/NADH,and the positive rate of EdU decreased(P<0.05,P<0.01).Compared with the D-gal+si-NC group,the positive rate of SA-β-gal,the expressions of IL-6,HMGB1,TNF-α,and the mRNA and protein expressions of PARP1,p16,and MMP-13 in the D-gal+si-PARP1 group decreased(P<0.05,P<0.01).The content of NAD+,the ratio of NAD+/NADH,and the positive rate of EdU increased(P<0.05,P<0.01).Results of experiment 2:Compared with the model group,the positive rate of SA-β-gal,the expressions of IL-6,HMGB1,and TNF-α in the treatment group and the inhibitor group decreased(P<0.05,P<0.01),while the content of NAD+,the ratio of NAD+/NADH,and the positive rate of EdU increased(P<0.05,P<0.01).The mRNA expressions of PARP1,p16,MMP-13 in the treatment group and p16,MMP-13 in the inhibitor group decreased(P<0.05),and the protein expressions of PARP1,PAR,p16,MMP-13 in the treatment group and PAR,p16,MMP-13 in the inhibitor group decreased(P<0.01).Conclusions RJNTF ameliorates chondrocyte senescence in KOA by inhibiting PARP1 expression,reducing the positive rate of SA-β-gal in chondrocytes,decreasing the consumption of NAD+in chondrocytes,promoting the proliferation of chondrocytes,down-regulating the expression of IL-6,HMGB1 and TNF-αcytokines and mRNA and protein expression of PARP1,p16 and MMP-13.

关键词

荣筋拈痛方/膝骨关节炎/软骨细胞衰老/多聚ADP核糖聚合酶1/中药复方

Key words

Rongjin Niantong Formula/knee osteoarthritis/chondrocyte senescence/PARP1/Chinese herbal compound

引用本文复制引用

李璐,郑若曦,戴雨婷,王如意,陈楠,陈俊,吴广文..荣筋拈痛方抑制PARP1延缓软骨细胞衰老治疗膝骨关节炎[J].中国中西医结合杂志,2026,46(1):67-74,8.

基金项目

国家自然科学基金资助项目(No.82405443,No.82474553) (No.82405443,No.82474553)

中国中西医结合杂志

1003-5370

访问量0
|
下载量0
段落导航相关论文